OR WAIT null SECS
August 04, 2015
Shire takes its offer for an all-stock transaction to combine with Baxalta to shareholders after Baxalta declines to discuss the proposal.
August 02, 2015
FDA notes progress in drug development, but cites scientific and funding roadblocks.
August 01, 2015
Contract development and manufacturing organizations join forces to address legislative, regulatory, and business concerns in the Pharma & Biopharma Outsourcing Association.
What if the expanding pipeline isn’t enough to fuel CMO growth?
Driven by competitive pressures and using models pioneered in other industries, pharmaceutical companies are extending collaboration efforts well beyond their walls.
Within the past few years, key players have left the sterile manufacturing business. Can new technology and investment revitalize this critical market?
July 24, 2015
As more patents make their way through IPRs, the balance of how the pharmaceutical industry selects between IPRs and district court litigation will likely evolve.
July 10, 2015
The 21st Century Cures Act took a giant step forward with a 344-77 approval in the House; the Senate debate is still ahead.
July 02, 2015
Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information.